Identification of Acute Intermittent Porphyria Modifying Genes
NCT05502133 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-08-28
Summary
This study proposes to identify the predisposing/protective modifying genes that underlie the acute attacks in symptomatic patients with Acute Intermittent Porphyria (AIP), an autosomal dominant inborn error of heme biosynthesis.
Conditions
- Acute Intermittent Porphyria (AIP)
Sponsors & Collaborators
-
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Robert J Desnick, Ph.D, MD · Icahn School of Medicine at Mount Sinai
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-23
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease
NCT04205123 ·Status: UNKNOWN
-
Acute Porphyria Biomarkers for Disease Activity
NCT02935400 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Individuals Affected With Hypoplasminogenemia
NCT03797495 ·Status: RECRUITING
-
Study of the Pathogenesis of Porphyria Cutanea Tarda
NCT00005103 ·Status: COMPLETED
-
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
NCT06944067 ·Status: RECRUITING
-
Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT00039923 ·Status: COMPLETED
-
"Association of Proteinuria and Progression of Kidney Dysfunction in Sickle Cell Disease"Disease
NCT05407740 ·Status: COMPLETED
-
Study of the Role of Genetic Modifiers in Hemoglobinopathies
NCT05799118 ·Status: RECRUITING
-
Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria
NCT03906214 ·Status: COMPLETED
-
The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals
NCT05370677 ·Status: UNKNOWN
-
Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
NCT00004396 ·Status: COMPLETED ·Phase: PHASE2
-
Cohort of Patients With Rare Iron Overloads Excluding C282Y Homozygosity
NCT02619955 ·Status: COMPLETED
-
Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data
NCT00005307 ·Status: COMPLETED
-
A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants
NCT06503458 ·Status: TERMINATED
-
The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
NCT05214105 ·Status: RECRUITING
-
Panhematin for Prevention of Acute Attacks of Porphyria
NCT02922413 ·Status: TERMINATED ·Phase: PHASE2
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
Bone Marrow for Hemoglobinopathy Research
NCT00669305 ·Status: COMPLETED
-
The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
NCT00230165 ·Status: RECRUITING
-
Light Exposure Patterns and Symptoms Among Patients With Erythropoietic Protoporphyria
NCT03682731 ·Status: COMPLETED
-
Molecular Biology of Polycythemia and Thrombocytosis
NCT00722527 ·Status: RECRUITING
-
Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria
NCT01550705 ·Status: TERMINATED ·Phase: NA
-
Studies in Porphyria I: Characterization of Enzyme Defects
NCT00004331 ·Status: UNKNOWN
-
Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
NCT02252159 ·Status: COMPLETED
-
Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic Anemia
NCT06743854 ·Status: NOT_YET_RECRUITING